Data of rheumatoid arthritis treatment study released
New data shows the non-inferiority of efficacy for the subcutaneous…
New data shows the non-inferiority of efficacy for the subcutaneous (SC) formulation of CT-P13 to the intravenous (IV) formulation of CT-P13 in people with rheumatoid arthritis.